Formulations containing triazinones and iron with a low amount of free iron ions
AssigneeBayer Animal Health GmbH
InventorsStefan Hofmann, Wolfgang Jiritschka
Life of this patent
Estimating the term…
Abstract
Formulations containing triazinones, selected from toltrazuril, ponazuril and diclazuril, a polynuclear iron(III) polysaccharide complex compound which are suitable for the simultaneous control of coccidiosis and anaemic states in animals and which exhibit a low amount of free iron ions even after storage, while the formulations comprises Ca2+ and Na+ in a molar ratio of Ca2+:Na+ from ≥0 to ≤3. In one embodiment the triazinone is toltrazuril and the polynuclear iron(III) polysaccharide complex compound is iron(III) dextran glucoheptonate.
Claims13
A formulation comprising a triazinone selected from the list consisting of toltrazuril, ponazuril and diclazuril, a polynuclear iron(III)polysaccharide complex compound, and a molar ratio of Ca2+ to Na+ from ≥0 to ≤3, with the exception of sodium propionate and/or sodium benzoate being the sole source of Na+ in the formulation when the molar ratio of Ca2+ to Na+ is 0.
A method of imparting a content of dissolved free iron of ≤3500 ppm in a formulation comprising a triazinone selected from the list consisting of toltrazuril, ponazuril and diclazuril, and a polynuclear iron(III) polysaccharide complex compound, after storage at a temperature of ≥20° C. to ≤40° C. for at least 6 months, the method comprising providing in the formulation Ca2+ and Na+ in a molar ratio of Ca2+ to Na+ from ≥0 to ≤3.
Dependencies are inferred from the claim text.